Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi

Journal of Clinical Microbiology

Volumn 37, Issue 12, 1999, Pages 3997-4004

  Lawrenz, M B ^a   Hardham, J M ^a,e   Owens, R T ^b   Nowakowski, J ^c   Steere, A C ^d   Wormser, G P ^c   Morris, S J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d Tupper Research Institute   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; MEMBRANE ANTIGEN VLSE; REAGENT; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ANTIGENIC VARIATION; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE DISRUPTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REPRODUCIBILITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALIA; BORRELIA; BORRELIA BURGDORFERI;

EID: 0032728088     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.12.3997-4004.1999     Document Type: Article

References (26)

1. Benach, J. L., E. M. Bosler, J. P. Hanrahan, J. L. Coleman, G. S. Habicht, T. F. Bast, D. J. Cameron, J. L. Ziegler, A. G. Harbour, W. Burgdorfer, R. Edelman, and R. A. Kaslow. 1983. Spirochetes isolated from the blood of two patients with Lyme disease. N. Engl. J. Med. 308:740-742.
2. Bradley, J. F., R. C. Johnson, and J. L. Goodman. 1994. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann. Intern. Med. 120: 487-489.
3. Brown, S. L., S. L. Hansen, and J. J. Langone. 1999. Role of serology in the diagnosis of Lyme disease. JAMA 282:62-66.
4. Centers for Disease Control. 1197. Lyme disease - United States, 1996. Morbid. Mortal. Weekly Rep. 46:531-553.
5. Coyle, P. K. 1997. Borrelia burgdorferi infection: clinical diagnostic techniques. Immunol. Investig. 26:117-128.
6. Golightly, M. G. 1997. Lyme borreliosis: laboratory considerations. Semin. Neurol. 17:11-17.
7. Lawrenz, M. B., J. M. Hardham, R. T. Owens, and S. J. Norris. 1999 Immunization with recombinant VlsE1 provides protection against Borrelia burgdorferi expressing the same VlsE variant, abstr. D/B-264, p. 260. In Abstracts of the 99th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
8. Lawrenz, M. B., and S. J. Norris, Unpublished data.
9. Liang, F., A. L. Alvarez, Y. Gu, J. M. Nowling, R. Ramamoorthy, and M. T. Philipp. 1999. An invariant, immunodominant and conserved region within the cassette segment of VlsE, the variant surface antigen of Borrelia burgdorferi sl. abstr. P408, p. 107. In Abstracts of the VIII International Conference on Lyme Borreliosis and Other Emerging Tick-Borne Diseases.
10. Liang, F. T., A. C. Steere, A. R. Marques, B. J. B. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
11. Magnarelli, L. A., J. F. Anderson, and R. C. Johnson. 1987. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J. Infect. Dis. 156:183-188.
12. Magnarelli, L. A., E. Fikrig, S. J. Padula, J. F. Anderson, and R. A. Flavell. 1996. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis. J. Clin. Microbiol. 34:237-240.
13. Nocton, J. J., B. J. Bloom, B. J. Rutledge, D. H. Persing, E. L. Logigian, C. H. Schmid, and A. C. Steere. 1996. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J. Infect. Dis. 174:623-627.
14. Nocton, J. J., and A. C. Steere. 1995. Lyme disease. Adv. Intern. Med. 40:69-117.
15. Norris, S. J., C. J. Carter, J. K. Howell, and A. G. Barbour. 1992. Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect. Immun. 60:4662-4672.
16. Norris, S. J., J. K. Howell, S. A. Garza, M. S. Ferdows, and A. G. Barbour. 1995. High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect. Immun. 63:2206-2212.
17. Phillips, S. E., L. H. Mattman, D. Hulinska, and H. Moayad. 1998. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infection 26:364-367.
18. Rosa, P. A. 1997. Microbiology of Borrelia burgdorferi. Semin. Neurol. 17:5-10.
19. Rosa, P. A., and T. G. Schwan. 1989. A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J. Infect. Dis. 160:1018-1029.
20. Sigal, L. H., J. M. Zahradnik, P. Lavin, S. J. Patella, G. Bryant, R. Haselby, E. Hilton, M. Kunkel, D. Adler-Klein, T. Doherty, J. Evans, and S. E. Malawista. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N. Engl. J. Med. 339:216-222.
21. Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, and D. S. Krause. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N. Engl. J. Med. 339:209-215.
22. Wormser, G. P., J. Nowakowski, R. B. Nadelman, S. Bittker, D. Cooper, and C. Pavia. 1998. Improving the yield of blood cultures for patients with early Lyme disease. J. Clin. Microbiol. 36:296-298.
23. Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285.
24. Zhang, J. R., and S. J. Norris. 1998. Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect. Immun. 66:3698-3704.
25. Zhang, J. R., and S. J. Norris. 1998. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect. Immun. 66:3689-3697.
26. Zhang, Y. Q., D. Mathiesen, C. P. Kolbert, J. Anderson, R. T. Schoen, E. Fikrig, and D. H. Persing. 1997. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection. J. Clin. Microbiol. 35:233-238.